Skip to Main Content

Paper Details

Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.
Eur Urol
25
2021
ATM, BRCA2, EMSY, FAM111A, FAM114A1, Familial Prostate Cancer, HNF1B, HOXB13, KLK3, MSMB, MUC6, MYCBP2, Novel Genes, PABPC1, PARTICIPANTS, PATIENT, PCAT1, PCa, PRSS3, Prostate Cancer, QK1, RAPGEF4, RNASEH2B, TERT, THAP3, ULK4, XPO7, custom-capture design, genetic variants, men, novel genes, patients, prostate cancer, prostate-specific antigen, risk alleles
Author NameAffiliation
Daniel J SchaidMayo Clinic
Shannon K McDonnellMayo Clinic
Graham G GilesThe University of Melbourne, Monash University, School of Clinical Sciences at Monash Health
Alice S WhittemoreStanford University
Weiva SiehIcahn School of Medicine at Mount Sinai
Janet L StanfordFred Hutchinson Cancer Research Center
Janet L StanfordFred Hutchinson Cancer Research Center
Johanna SchleutkerInstitute of Biomedicine, University of Turku, Turku University Hospital
Johanna SchleutkerInstitute of Biomedicine, University of Turku, Turku University Hospital
John D CarptenUniversity of Southern California
Douglas F EastonThe Institute of Cancer Research
Zsofia Kote-JaraiThe Institute of Cancer Research
Michael J AckermanMayo Clinic
Kathleen A CooneyDepartment of Medicine and Duke Cancer Institute, Duke University School of Medicine
Kathleen A CooneyDepartment of Medicine and Duke Cancer Institute, Duke University School of Medicine
Fredrik WiklundKarolinska Institutet
Melissa C LarsonMayo Clinic
Jianfeng XuNorthshore University Health System
William B IsaacsJohns Hopkins Hospital
Elaine A OstranderNational Human Genome Research Institute, National Institutes of Health
Elaine A OstranderNational Human Genome Research Institute, National Institutes of Health
Stephen N ThibodeauMayo Clinic
  • 1 - 22

Datasets

Release 1.2